| 11β-HSD1 | 11β-hydroxysteroid dehydrogenase type 1 |
| A2780 | Human ovarian cancer cells |
| A549 | Human lung adenocarcinoma cells |
| C6 | Cellosaurus cell line |
| Colo320 | Human colon adenocarcinoma cells |
| DOX | Doxorubicin |
| DPPH | 1,1-diphenyl-2-pycrylhydrazyl |
| DU-145 | Human prostate cancer cells |
| EBV-EA | Epstein-Barr virus cells |
| GI50 | Growth inhibition—concentration at which cell is inhibited by 50% |
| HCT 116 | Human colorectal adenocarcinoma cells |
| HeLa | Human normal cells |
| HepG2 | Human liver carcinoma cells |
| HL60 | Promyelocytic leukemia cells |
| HT-3 | Human cervix cells |
| IC50 | Inhibitory concentration |
| K562 | Human immortalized myelogenous leukemia cells |
| MCF-7 | Human breast cancer cell lines |
| MDR1 | Multidrug resistance gene 1 |
| MRC-5 | Human embryonic fibroblast cell lines |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| P-gp | Permeability glycoprotein |
| SGC-7901 | Human gastric cancer cell line |
| SMMC-7721 | Human hepatoma cell line |
| SRB | Sulforhodamine B assay |
| TNFR1 | Tumor necrosis factor receptor 1 |
| U937 | Human myeloid leukemia |